About BioAgilytix
BioAgilytix is a company based in Durham (United States) founded in 2008 was acquired by Cinven in November 2021. BioAgilytix has completed 4 acquisitions, including 360biolabs, Cambridge Biomedical and IPM Biotech. BioAgilytix offers products and services including Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing. BioAgilytix operates in a competitive market with competitors including Advion, Tentamus, Nordic Bioscience, Alderley Analytical and Evans Analytical Group, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioagilytix Labs, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
GHO Capital
& 3 more
-
Employee Count
Not available
-
Investments & Acquisitions
360biolabs
& 3 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioAgilytix
BioAgilytix offers a comprehensive portfolio of products and services, including Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing.
Streamlines processes for successful assay method transfers in development.
Develops and validates custom assays for bioanalytical needs.
Provides accurate analysis of samples for preclinical and clinical trials.
Produces customized specimen collection kits for clinical trials.
Offers testing for infectious diseases and immunology diagnostics.
People of BioAgilytix
Unlock access to complete
Funding Insights of BioAgilytix
Investors in BioAgilytix
BioAgilytix has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include GHO Capital, Riverside Partners and Cobepa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specialist healthcare investment advisory services are provided by GHO Capital.
|
Locked | Locked | Locked | |
|
Private equity investments are made in technology and healthcare sectors.
|
Locked | Locked | Locked | |
|
Cobepa is recognized as an independent investment company.
|
Locked | Locked | Locked |
Investor details for BioAgilytix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioAgilytix
BioAgilytix has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include 360biolabs, Cambridge Biomedical and IPM Biotech.
Investment portfolio details for BioAgilytix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Contract virology and immunology services are provided by 360biolabs.
|
Locked | Locked | 2015 | Locked | |
|
Biomarkers, cytometry, PCR, and ELISA machines are manufactured.
|
Locked | Locked | 2008 | Locked | |
|
CRO specialising in bioanalysis & DMPK assays
|
Locked | Locked | 1998 | Locked |
Complete acquisition details for BioAgilytix
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BioAgilytix
Detailed financials for BioAgilytix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioagilytix Comparisons
Peer comparison for BioAgilytix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioAgilytix
BioAgilytix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advion, Tentamus, Nordic Bioscience, Alderley Analytical and Evans Analytical Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
Detailed competitors of BioAgilytix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioagilytix
Complete news archive for BioAgilytix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioAgilytix
BioAgilytix was founded in 2008 and raised its 1st funding round 11 years after it was founded.
BioAgilytix is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
BioAgilytix was founded in 2008 and is headquartered in Durham, North Carolina, within the Research Triangle Park area. Operations are conducted as a bioanalytical contract research organization in the biotechnology sector. Services encompass assay development, validation, and sample analysis for immunoassays and cell-based assays, performed under non-GLP, spirit-of-GLP, and GLP guidelines. GMP-compliant product release testing is also handled to support clinical trials for therapeutic biologics and biosimilars.
BioAgilytix's top competitors include Alderley Analytical, Lightcast Discovery and Solvias.
BioAgilytix offers Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing.
BioAgilytix has made 4 acquisitions, including 360biolabs, Cambridge Biomedical, and IPM Biotech.
BioAgilytix has 4 investors. Key investors include GHO Capital, Riverside Partners, Cobepa, and Cinven.